Treatment guidelines from the American College of Physicians (ACP) for adult patients with anemia and heart disease include the following:
A restrictive red blood cell transfusion strategy is recommended for hospitalized patients with coronary heart disease, with the trigger hemoglobin threshold lowered to 7-8 g/dL (recommendation: weak; quality of evidence: low)
Erythropoiesis-stimulating agents are not recommended for patients with mild to moderate anemia and either congestive heart failure or coronary heart disease (recommendation: strong; quality of evidence: moderate)
Parenteral iron has been safely and effectively used in patients with irritable bowel disease, such as ulcerative colitis or Crohn disease. Oral iron supplements may aggravate intestinal inflammation in patients with these diseases.
Oral ferrous iron salts are both economical and effective medications for the treatment of iron-deficiency anemia.
Learn more about the treatment of iron-deficiency anemia.
Medscape © 2021 WebMD, LLC
Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.
Cite this: Emmanuel C. Besa, Derek B. Laskar. Fast Five Quiz: How Familiar Are You With Iron-Deficiency Anemia? - Medscape - May 18, 2021.